Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis

A. Van Deun, A.K.J. Maug, A. Hossain, M. Gumusboga, B.C. de Jong

Research output: Contribution to journalA1: Web of Science-article

1 Downloads (Pure)

Abstract

SETTING: Damien Foundation Project, Bangladesh. OBJECTIVE: To evaluate sputum smear fluorescein diacetate (FDA) vital staining to predict culture-defined failure and rifampicin (RMP) resistance. DESIGN: A retrospective, operational study. RESULTS: A total of 1633 episodes of auramine smear-defined late conversion and failure could be evaluated (respectively 640 and 584 on first treatment and 185 and 224 on retreatment). Negative FDA was 95% predictive of negative culture in patients on first treatment, while its positive predictive value was around 95% during retreatment. The predictive value of a positive (not scanty) result for RMP resistance or environmental nontuberculous mycobacteria (NTM) was at least 90%, except in late converters on first-line treatment; a negative result was over 95% exclusive of the same except in r etreatment failures. FDA correctly identified 88-98% of all RMP resistance. CONCLUSIONS: FDA staining increased the proportion of tuberculosis patients put on second-line treatment without receiving the standard first-line retreatment regimen. In our setting, with excellent microscopy, late case presentation and low resistance prevalence, it proved indispensable for efficient culture and referrals of early suspects for rapid drug susceptibility testing (DST). In other settings with low prevalence of NTM and difficult access to accurate and rapid DST, FDA-positive failures might even be considered for immediate start of second-line treatment.
Original languageEnglish
JournalInternational Journal of Tuberculosis and Lung Disease
Volume16
Issue number9
Pages (from-to)1174-1179
Number of pages6
ISSN1027-3719
DOIs
Publication statusPublished - 2012

Keywords

  • Bacterial diseases
  • Tuberculosis
  • Mycobacterium tuberculosis
  • Early detection
  • Diagnosis
  • Drug resistance
  • Rifampicin
  • Staining
  • Smear microscopy
  • Auramine
  • Fluorescein diacetate
  • Predictive value
  • Second-line drugs
  • Management
  • Laboratory techniques and procedures

Fingerprint Dive into the research topics of 'Fluorescein diacetate vital staining allows earlier diagnosis of rifampicin-resistant tuberculosis'. Together they form a unique fingerprint.

Cite this